Who We Are
Vadim J. Gurvich, Ph.D., M.B.A.
Vadim J. Gurvich, Ph.D., M.B.A. is Associate Director of the Institute for Therapeutics Discovery and Development (ITDD) and Research Associate Professor in the Department of Medicinal Chemistry at the University of Minnesota. Since 2007, Dr. Gurvich has also served as the Associate Director of the National Institute for Pharmaceutical Technology and Education (NIPTE), a national consortium of leading schools and colleges of Pharmacy and Chemical Engineering. Dr Gurvich is an expert in synthetic organic and medicinal chemistry, drug synthesis and chemical process development and engineering. Dr. Gurvich holds a doctoral degree in organic chemistry along with master’s degrees in chemical engineering and business administration (MBA) and possesses over 25 years of academic and industrial research and development experience.
Bin He, Ph.D.
Bin He is Distinguished McKnight University Professor of Biomedical Engineering, Medtronic-Bakken Endowed Chair for Engineering in Medicine, and director of Institute for Engineering in Medicine at the University of Minnesota, Twin Cities. Dr. He has made significant research contributions to the fields of neuroengineering, functional biomedical imaging, and medical instrumentation. Dr. He has published over 210 peer-reviewed scientific articles in leading international journals with an h-index of 50 and total citations of over 8000.
Dr. He is a Fellow of International Academy of Medical and Biological Engineering, IEEE, the American Institute of Medical and Biological Engineering (AIMBE), the Institute of Physics (U.K.), and the International Society for Functional Source Imaging. He is an Honorary Professor or Visiting Professor at multiple universities.
Dr. He served as Past President of the IEEE Engineering in Medicine and Biology Society, International Society for Functional Source Imaging, and International Society for Bioelectromagnetism. Dr. He is on the Governing Council of the International Academy of Medical and Biological Engineering, the Board of Directors of the American Institute of Medical and Biological Engineering, and the Administrative Committee of IEEE Engineering in Medicine and Biology Society. He is also a Member of the NIH BRAIN Multi-Council Working Group. Dr. He is the Editor-in-Chief of IEEE Transactions on Biomedical Engineering, and on the editorial boards of eight other journals.
Allison Hubel, Ph.D.
Allison Hubel, Ph.D., is Co-PI and MN-REACH Deputy Director spearheading the educational and skills development activities of MN-REACH. Dr. Hubel is Professor of Mechanical Engineering and Director of the Biopreservation Core Resource (BioCoR), the nations only resource on preservation. Her research in preservation has been translational and has resulted in numerous publications, several patents and the foundation of a small start-up company, Mesoflow, which is commercializing NIH-funded research in the field of preservation. Dr. Hubel also enjoys creating and implementing professional development courses with multidisciplinary themes and faculty and has been involved in programs for faculty development such as the Big Ten Women’s Workshop.
Charles Muscoplat, Ph.D.
Dr. Charles Muscoplat holds positions as professor of medicine and microbiology in the Medical School; professor of Food Science and Nutrition in the College of Food, Agricultural and Natural Resource Sciences; and has chaired the University’s Committee for Pharmaceutical Development (CPD) from 2011 until 2015. The CPD is an internal new program to offer funding and coaching for faculty pharmaceutical projects.
From 1999 until 2006, Dr. Muscoplat was vice president for agricultural policy and dean of the College of Agricultural, Food, and Environmental Sciences at the University of Minnesota. Dr. Muscoplat is now Dean Emeritus. From 1981 until 1999, Dr. Muscoplat was vice president for medical affairs of MGI PHARMA, Inc., and was instrumental in bringing several biotechnology and biopharmaceutical products to the market. He developed new drug therapies for cancer patients with post-radiation xerostomia, and also for xerostomia and sicca syndrome in patients with Sjogrens Syndrome. Dr. Muscoplat is currently conducting clinical research with transdermal vitamin D in patient with vitamin D deficiency. Muscoplat consults in the biopharmaceutical industry.
Dr. Muscoplat received his bachelor's in chemistry in 1970, with a minor in mathematics, and his Ph.D. in veterinary microbiology in 1975 from the University of Minnesota. Dr. Muscoplat did post-doctoral training at the Memorial Sloan-Kettering Cancer Center in New York City.
Kevin A. Peterson, MD, MPH, FRCS(Ed), FAAFP
Dr. Peterson is a Professor in the Medical School where he directs the Center of Excellence in Primary Care with additional appointments in the Institute for Engineering in Medicine and the Institute for Health Informatics. His training includes Mayo Medical School, Johns Hopkins Hospital, Leeds University (England), Rush Presbyterian, and the University of Minnesota. Dr. Peterson is a Fellow of the Royal College of Surgeons (Edinburgh) and American Academy of Family Physicians. Dr. Peterson has led many NIH studies and licensed several technologies. As the national Director for the AHRQ PBRN Resource Center, his national team provided research support for over 17,000 practices and 70,000 clinician-researchers throughout the US and territories. With over 20 years of translational research experience, Dr. Peterson’s research focuses on clinical trials, diabetes and chronic disease, innovations in health care, and dissemination science. He works with health systems, national and international industry partners, and academic medical centers across the world in clinical trials of comparative effectiveness, community engagement, and engineering new approaches to improve health care delivery. Dr. Peterson functions as the Medical Advisor to MN-REACH, promoting the engagement of clients and communities early in the development and commercialization process.
Amy H. Moore is a project manager for MN-REACH and a University of Minnesota consultant. She is responsible for technical program functions including management and oversight of MN-REACH support services for project teams preparing full proposals. In this role, Moore assigns and facilitates coaching teams, serves as coach, acts as liaison to industry experts and external advisors, conducts market, technical and academic research, prepares federal and technical reports, and related.
Moore utilizes her 15 years of experience as a biomedical scientist and clinical educator to translate the value of your scientific discovery or medical innovation to multiple stakeholders through commercialization strategy, publication planning, competitive intelligence, and science communication. Amy earned a PhD in neuroscience from UCLA and an MBA with Medical Industry Specialization from Carlson School of Management at University of Minnesota. Current and past projects with academic institutions, federal funding agencies, start-up companies, and Fortune 500 companies span the life science industry from biomedical therapies to health care IT to clean energy technology.
Lorri Chapman is a project manager for MN-REACH, responsible for administrative and program functions including day-to-day office operations, website and technology, communications, budget and contracts, PI and ERB support, metrics and reporting, and related program functions. She has worked at the University twelve years, previously on a large real estate project and as executive assistant to the VP for Ag. Policy and Dean of the College of Food, Agricultural and Natural Resource Sciences. In her roles, Chapman has established and cultivated professional relationships throughout the University system. Chapman has also held positions at the West Metro Education Program, University of St. Thomas School of Education, and the Minnesota Health & Housing Alliance.
She has extensive experience in project management that includes facilitating the move for the St. Thomas School of Education from the St. Paul campus to Minneapolis campus; establishing procedural and programmatic policies and systems for new offices and programs; coordinating educational workshops for as few as ten to upwards of 3,000 participants; and developing health care policy instructional and resource manuals.